Related Experiment Video
Updated: Jun 18, 2026

Non-invasive Assessment of Microvascular and Endothelial Function
Published on: January 29, 2013
The National Heart Lung and Blood Institute Disparities Elimination through Coordinated Interventions to Prevent and
Abel Kho1, Gail L Daumit2, Kimberly P Truesdale3
1Center for Health Information Partnerships (CHiP), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Objective:
To describe the National Heart Lung and Blood Institute (NHLBI) sponsored Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease (DECIPHeR) Alliance to support late-stage implementation research aimed at reducing disparities in communities with high burdens of cardiovascular and/or pulmonary disease.
Study Setting:
NHBLI funded seven DECIPHeR studies and a Coordinating Center. Projects target high-risk diverse populations including racial and ethnic minorities, urban, rural, and low-income communities, disadvantaged children, and persons with serious mental illness. Two projects address multiple cardiovascular risk factors, three focus on hypertension, one on tobacco use, and one on pediatric asthma.
Study Design:
The initial phase supports planning activities for sustainable uptake of evidence-based interventions in targeted communities. The second phase tests late-stage evidence-based implementation strategies.
Data Collection/Extraction Methods:
Not applicable.
Principal Findings:
We provide an overview of the DECIPHeR Alliance and individual study designs, populations, and settings, implementation strategies, interventions, and outcomes. We describe the Alliance's organizational structure, designed to promote cross-center partnership and collaboration.
Conclusions:
The DECIPHeR Alliance represents an ambitious national effort to develop sustainable implementation of interventions to achieve cardiovascular and pulmonary health equity.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care

